Results 241 to 250 of about 345,077 (288)
Some of the next articles are maybe not open access.
Endocrinology and Metabolism Clinics of North America, 2021
Significant development has occurred in the treatment of postmenopausal osteoporosis. We review the most recent guidelines from the American Association of Clinical Endocrinologists/American College of Endocrinology, Endocrine Society, and the European ...
Rod Marianne Arceo-Mendoza +1 more
openaire +2 more sources
Significant development has occurred in the treatment of postmenopausal osteoporosis. We review the most recent guidelines from the American Association of Clinical Endocrinologists/American College of Endocrinology, Endocrine Society, and the European ...
Rod Marianne Arceo-Mendoza +1 more
openaire +2 more sources
Medical Clinics of North America, 1987
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
+9 more sources
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
+9 more sources
Current Opinion in Endocrinology, Diabetes & Obesity, 2013
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
Current Osteoporosis Reports, 2004
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +4 more sources
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +4 more sources
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.
Maturitas, 2021In postmenopausal women, osteoporosis may coexist with other metabolic diseases, including, but not limited to, obesity, diabetes, nonalcoholic fatty liver disease (NAFLD), dyslipidemia and cardiovascular disease (CVD).
S. Polyzos +4 more
semanticscholar +1 more source
Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis
Medicinal research reviews (Print)Postmenopausal osteoporosis (PMO) is a common disease associated with aging, and estrogen deficiency is considered to be the main cause of PMO. Recently, however, osteoimmunology has been revealed to be closely related to PMO.
Yao Yao +4 more
semanticscholar +1 more source
Postmenopausal osteoporosis management
Current Opinion in Obstetrics and Gynecology, 2000Osteoporosis is perhaps the widest-ranging social, physical, and economic impact of estrogen deficiency. Postmenopausal bone loss is the major determinant of osteoporosis. Osteoporotic risk can be determined by measuring bone mineral density using dual X-ray absorptiometry.
M, Gambacciani, M, Ciaponi
openaire +2 more sources
Management of postmenopausal osteoporosis
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1994More than 25% of postmenopausal women are at risk of osteoporosis. In order to avoid its consequences, it is necessary to find an appropriate prevention and/or treatment. We studied: (1) 15 postmenopausal women treated with percutaneous estradiol (50 micrograms/24 h) plus MPA (10 mg/10 days/month); (2) 15 postmenopausal women treated with synthetic ...
DI RENZO, Giancarlo +5 more
openaire +5 more sources
Cytokine & growth factor reviews, 2020
Postmenopausal osteoporosis (PMOP) is a prevalent skeletal disorder associated with menopause-related estrogen withdrawal. PMOP is characterized by low bone mass, deterioration of the skeletal microarchitecture, and subsequent increased susceptibility to
Jiao Li +3 more
semanticscholar +1 more source
Postmenopausal osteoporosis (PMOP) is a prevalent skeletal disorder associated with menopause-related estrogen withdrawal. PMOP is characterized by low bone mass, deterioration of the skeletal microarchitecture, and subsequent increased susceptibility to
Jiao Li +3 more
semanticscholar +1 more source
Journal of the American Medical Association, 1941
Our object in this paper is to point out the existence of postmenopausal osteoporosis and to describe its clinical features. Some metabolic data showing the effects of therapy with estrogens and other agents are incorporated in other papers.1 It will probably be well to start by explaining and defining the term "osteoporosis." Adult bone is normally ...
FULLER ALBRIGHT +2 more
openaire +1 more source
Our object in this paper is to point out the existence of postmenopausal osteoporosis and to describe its clinical features. Some metabolic data showing the effects of therapy with estrogens and other agents are incorporated in other papers.1 It will probably be well to start by explaining and defining the term "osteoporosis." Adult bone is normally ...
FULLER ALBRIGHT +2 more
openaire +1 more source